Immunotherapy added to radiation therapy boosts survival in localized prostate cancer
Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy aglatimagene besadenovec (alglatimagene, CAN-2409) to standard radiation therapy improved ...
2 Jun 20:40 · Medical Xpress